193 related articles for article (PubMed ID: 9301503)
1. N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions.
Hubbard AL; Harrison DJ; Moyes C; Wyllie AH; Cunningham C; Mannion E; Smith CA
Gut; 1997 Aug; 41(2):229-34. PubMed ID: 9301503
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer.
Gil JP; Lechner MC
Carcinogenesis; 1998 Jan; 19(1):37-41. PubMed ID: 9472690
[TBL] [Abstract][Full Text] [Related]
3. Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.
Rodriguez JW; Kirlin WG; Ferguson RJ; Doll MA; Gray K; Rustan TD; Lee ME; Kemp K; Urso P; Hein DW
Arch Toxicol; 1993; 67(7):445-52. PubMed ID: 7902079
[TBL] [Abstract][Full Text] [Related]
4. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
5. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
6. Relationship between polymorphism of N-acetyltransferase gene and susceptibility to colorectal carcinoma in a Chinese population.
Lee EJ; Zhao B; Seow-Choen F
Pharmacogenetics; 1998 Dec; 8(6):513-7. PubMed ID: 9918135
[TBL] [Abstract][Full Text] [Related]
7. Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer.
Thygesen P; Risch A; Stacey M; Fakis G; Giannoulis F; Takle L; Knowles M; Sim E
Pharmacogenetics; 1999 Feb; 9(1):1-8. PubMed ID: 10208636
[TBL] [Abstract][Full Text] [Related]
8. N-acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: risk variability according to tumour site?
Agúndez JAG ; Lozano L; Ladero JM; Sastre J; Cerdán FJ; Diaz-Rubio M; Benítez J
Scand J Gastroenterol; 2000 Oct; 35(10):1087-91. PubMed ID: 11099063
[TBL] [Abstract][Full Text] [Related]
9. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan.
Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Chou MC; Lee H
Dis Colon Rectum; 2007 Jul; 50(7):981-9. PubMed ID: 17525862
[TBL] [Abstract][Full Text] [Related]
10. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.
da Silva TD; Felipe AV; de Lima JM; Oshima CT; Forones NM
World J Gastroenterol; 2011 Feb; 17(6):760-5. PubMed ID: 21390146
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NAT1 cosmid clone: an investigation in bladder cancer by interphase FISH.
Stacey M; Matas N; Drake M; Payton M; Fakis G; Greenland J; Sim E
Genes Chromosomes Cancer; 1999 Aug; 25(4):376-83. PubMed ID: 10398432
[TBL] [Abstract][Full Text] [Related]
12. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes.
Frazier ML; O'Donnell FT; Kong S; Gu X; Campos I; Luthra R; Lynch PM; Amos CI
Cancer Res; 2001 Feb; 61(4):1269-71. PubMed ID: 11245417
[TBL] [Abstract][Full Text] [Related]
13. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
14. NAT2 gene polymorphism and sporadic colorectal cancer. Prevalence, tumor stage and prognosis. A preliminary study in 70 patients.
Osian G; Procopciuc L; Vlad L
J Gastrointestin Liver Dis; 2006 Dec; 15(4):347-53. PubMed ID: 17205146
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 2 gene polymorphism in patients with colorectal carcinoma.
Tamer L; Ercan B; Ateş NA; Değirmenci U; Unlü A; Ateş C; Dirlik M; Atik U
Cell Biochem Funct; 2006; 24(2):131-5. PubMed ID: 15617035
[TBL] [Abstract][Full Text] [Related]
16. NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer.
Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Lee H
Environ Mol Mutagen; 2009 Mar; 50(2):127-33. PubMed ID: 19107910
[TBL] [Abstract][Full Text] [Related]
17. Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients.
Schnakenberg E; Ehlers C; Feyerabend W; Werdin R; Hübotter R; Dreikorn K; Schloot W
Clin Genet; 1998 May; 53(5):396-402. PubMed ID: 9660060
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
[TBL] [Abstract][Full Text] [Related]
19. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer.
Chen J; Stampfer MJ; Hough HL; Garcia-Closas M; Willett WC; Hennekens CH; Kelsey KT; Hunter DJ
Cancer Res; 1998 Aug; 58(15):3307-11. PubMed ID: 9699660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
